Recent studies reveal that TRIM24 is upregulated in glioblastoma and gastric cancer, and promotes tumor growth and induces chemotherapy resistance via the phosphatidylinositide 3-kinase (PI3K)/Akt pathway [13, 14]. The gene discussed is TRIM24; the disease is neoplasm.